1-(2,3-Anhydro-β-D-lyxofuranosyl)uracil | 1217886-04-8

• 分子结构分类: 有机化合物 - 核苷、核苷酸和类似物 - 核苷和核苷酸类似物
• 英文名称: 1-(2,3-Anhydro-β-D-lyxofuranosyl)uracil
• 英文别名: 1-(5-hydroxymethyl-2,5-dihydro-furan-2-yl)-1H-pyrimidine-2,4-dione；1-[(2S,5R)-5-(hydroxymethyl)-2,5-dihydrofuran-2-yl]pyrimidine-2,4-dione
• CAS: 1217886-04-8
• 化学式: C₉H₁₀N₂O₄
• 分子量: 210.189
• InChiKey: NZXWQUCGACTHLK-SVRRBLITSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  -1.1
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.33
• 拓扑面积：
  78.9
• 氢给体数：
  2
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  1-(2,3-Anhydro-β-D-lyxofuranosyl)uracil 、 苯甲酰氯 、 劳森试剂 生成 [(2R,5S)-5-(2-oxo-4-sulfanylidenepyrimidin-1-yl)-2,5-dihydrofuran-2-yl]methyl benzoate
  参考文献：
  名称：

  MANSURI, MUZAMMIL M.;FARINA, VITTORIO;STARRETT, JOHN E. (JR);BENIGNI, DAN+, BIOORG. AND MED. CHEM. LETT., 1,(1991) N, C. 65-68

  摘要：

  DOI：
• 作为产物：
  描述：

  1-O-acetyl-2,3,4-tri-O-benzoyl-L-ribofuranose 生成 1-(2,3-Anhydro-β-D-lyxofuranosyl)uracil
  参考文献：
  名称：

  MANSURI, MUZAMMIL M.;FARINA, VITTORIO;STARRETT, JOHN E. (JR);BENIGNI, DAN+, BIOORG. AND MED. CHEM. LETT., 1,(1991) N, C. 65-68

  摘要：

  DOI：

文献信息

• Nucleotide mimics and their prodrugs
  申请人：——

  公开号：US20040059104A1

  公开（公告）日：2004-03-25

  The present invention relates to nucleoside diphosphate mimics and nucleoside triphosphate mimics, which contain diphosphate or triphosphate moiety mimics and optionally sugar-modifications and/or base-modifications. The nucleotide mimics of the present invention, in a form of a pharmaceutically acceptable salt, a pharmaceutically acceptable prodrug, or a pharmaceutical formulation, are useful as antiviral, antimicrobial, and anticancer agents. The present invention provides a method for the treatment of viral infections, microbial infections, and proliferative disorders. The present invention also relates to pharmaceutical compositions comprising the compounds of the present invention optionally in combination with other pharmaceutically active agents.

  本发明涉及核苷二磷酸模拟物和核苷三磷酸模拟物，其中包含二磷酸或三磷酸基团模拟物，以及可选的糖修饰和/或碱基修饰。本发明的核苷酸模拟物，以药学上可接受的盐、药学上可接受的前药或药物配方的形式，可用作抗病毒、抗微生物和抗癌剂。本发明提供了一种治疗病毒感染、微生物感染和增生性疾病的方法。本发明还涉及包含本发明化合物的药物组合物，可选地与其他药理活性剂结合。
• PROCESS FOR PREPARING DISULPHIDES AND THIOSULPHINATES AND COMPOUNDS PREPARED
  申请人：Decout Jean-Luc

  公开号：US20090264637A1

  公开（公告）日：2009-10-22

  Process for preparing a compound of the formula (I) R1-S(O) x —S(O) y R2 in which R1 represents a molecular hydrocarbon radical which can be substituted and/or interrupted by one or more atoms and/or by one or more groups containing one or more atoms, said atoms being selected from N, O, P, S, Si and X, where X represents a halogen; R2, independently of R1, represents a carbon-containing group or a molecular hydrocarbon radical which can be substituted and/or interrupted by one or more atoms and/or by one or more groups containing one or more atoms, said atoms being selected from N, O, P, S, Si and X, where X represents a halogen, and x and y are selected from 0 and 1 in such a way that the sum of x and y is not more than 1, characterized in that a compound of formula (II) R1-S(O) x —R3-Si(R4)(R5)(R6) in which R3 represents a hydrocarbon chain of two carbon atoms, which is optionally unsaturated and/or substituted, and R4, R5 and R6, which are identical or different, each represent, independently of one another, a hydrocarbon group, is reacted with a compound of formula (VII) R2-S(O) y —X in which X represents a halogen, intermediate compounds, and compounds prepared.

  制备化合物的过程（I）R1-S(O)x—S(O)yR2的公式，其中R1代表一个可以被一个或多个原子和/或一个或多个含有一个或多个原子的基团取代和/或中断的分子烃基团，所述原子选自N、O、P、S、Si和X，其中X代表一个卤素；独立于R1，R2代表一个含碳基团或一个可以被一个或多个原子和/或一个或多个含有一个或多个原子的基团取代和/或中断的分子烃基团，所述原子选自N、O、P、S、Si和X，其中X代表一个卤素，x和y选自0和1，使得x和y的和不超过1，其特征在于将公式（II）R1-S(O)x—R3-Si(R4)(R5)(R6)中R3代表一个含有两个碳原子的烃链，可以是不饱和和/或取代的，R4、R5和R6，它们相同或不同，每个独立地代表一个烃基团，与公式（VII）R2-S(O)y—X中的X代表一个卤素的化合物反应，中间化合物和制备的化合物。
• [EN] NOVEL PHOSPH(ON)ATE- AND SULF(ON)ATE-BASED PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS<br/>[FR] NOUVEAUX NUCLÉOSIDES MODIFIÉS AVEC UN PHOSPHATE, À BASE DE PHOSPH(ON)ATE ET DE SULF(ON)ATE, UTILES COMME SUBSTRATS POUR LES POLYMÉRASES ET COMME AGENTS ANTIVIRAUX
  申请人：UNIV LEUVEN KATH

  公开号：WO2011069688A1

  公开（公告）日：2011-06-16

  This invention provides phosphate-modified nucleosides represented by the structural formula ( I ): wherein W is O or S, and wherein B, R1; R3 and R2. are as defined herein. These compounds are useful as substrates for DNA/RNA polymerases, and as anti-viral agents in particular against HIV-1.

  这项发明提供了由结构式（I）表示的磷酸酯修饰核苷，其中W为O或S，B、R1、R3和R2的定义如本文所述。这些化合物可作为DNA/RNA聚合酶的底物使用，特别是作为抗HIV-1的抗病毒药物。
• NOVEL PHOSPH(ON)ATE- AND SULF(ON)ATE-BASED PHOSPHATE MODIFIED NUCLEOSIDES USEFUL AS SUBSTRATES FOR POLYMERASES AND AS ANTIVIRAL AGENTS
  申请人：Herdewijn Piet

  公开号：US20120245029A1

  公开（公告）日：2012-09-27

  This invention provides phosphate-modified nucleosides represented by the structural formula (I): wherein W is O or S, and wherein B, R 1 ; R 3 and R 2 . are as defined herein. These compounds are useful as substrates for DNA/RNA polymerases, and as anti-viral agents in particular against HIV-1.

  这项发明提供了由结构式(I)表示的磷酸修饰核苷酸，其中W为O或S，而B、R1、R2和R3如此处所定义。这些化合物可作为DNA/RNA聚合酶的底物，特别是在抗击HIV-1方面作为抗病毒剂。
• [EN] ANTI-VIRAL AND HEPATIC-TARGETED DRUGS<br/>[FR] MÉDICAMENTS ANTIVIRAUX ET CIBLÉS SUR LE FOIE
  申请人：AI BIOPHARMA

  公开号：WO2021074443A1

  公开（公告）日：2021-04-22

  Disclosed herein are identified compound fragments, compounds and their pharmaceutically acceptable salts, isotopes or solvates, useful as antiviral drug and/or as a hepatic-targeted drug, such as for the treatment of HBV, HDV and/or HIV. Formula (I).

  本文揭示了被识别的化合物片段、化合物及其药学上可接受的盐、同位素或溶剂化合物，用作抗病毒药物和/或肝靶向药物，例如用于治疗HBV、HDV和/或HIV。公式（I）。